Breaking News Instant updates and real-time market news.

TGB

Taseko Mines

$1.08 /

+0.07 (+6.93%)

10:52
08/10/22
08/10
10:52
08/10/22
10:52

Taseko Mines price target lowered to C$2.25 from C$2.50 at TD Securities

TD Securities analyst Craig Hutchison lowered the firm's price target on Taseko Mines to C$2.25 from C$2.50 and keeps a Buy rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Periodicals
SPAC bubble has burst, Blue Owl Luminar still have potential, Barron's says » 09:48
10/01/22
10/01
09:48
10/01/22
09:48
OWL

Blue Owl Capital

$9.22 /

-0.06 (-0.65%)

, CHPT

ChargePoint

$14.78 /

-0.15 (-1.00%)

, LAZR

Luminar

$7.29 /

-0.08 (-1.09%)

, RKLB

Rocket Lab

$4.08 /

-0.075 (-1.81%)

, VCSA

Vacasa

$3.07 /

-0.04 (-1.29%)

, SEAT

Vivid Seats

$7.67 /

+0.08 (+1.05%)

One year ago, investors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

09/12/22 Deutsche Bank
Blue Owl Capital initiated with a Buy at Deutsche Bank
07/11/22 JPMorgan
Blue Owl Capital initiated with a Neutral at JPMorgan (Thursday)
06/08/22 JMP Securities
Blue Owl Capital initiated with an Outperform at JMP Securities
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

09/07/22 Credit Suisse
ChargePoint initiated with an Outperform at Credit Suisse
08/31/22 Oppenheimer
ChargePoint results strong despite supply headwinds, says Oppenheimer
08/31/22 JPMorgan
ChargePoint leadership remains underappreciated, says JPMorgan
08/23/22 JPMorgan
ChargePoint price target raised to $20 from $18 at JPMorgan
LAZR Luminar
$7.29 /

-0.08 (-1.09%)

09/28/22 Berenberg
Berenberg assumes LiDAR stocks, recommends Innoviz over Luminar
09/28/22 Berenberg
Luminar assumed with a Hold at Berenberg
09/22/22 Northland
Luminar downgraded to Market Perform from Outperform at Northland
09/20/22 JPMorgan
Luminar initiated with an Overweight at JPMorgan
RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

06/29/22 JPMorgan
Vacasa price target lowered to $6 from $9 at JPMorgan
06/09/22 Goldman Sachs
Vacasa price target lowered to $5.50 from $9 at Goldman Sachs
06/09/22 JMP Securities
Vacasa assumed with an Outperform at JMP Securities
03/29/22 KeyBanc
End-market data analysis suggests consumer travel holding up well, says KeyBanc
SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

08/29/22 RBC Capital
RBC starts Vivid Seats at Sector Perform, sees position balanced by valuation
08/29/22 RBC Capital
Vivid Seats initiated with a Sector Perform at RBC Capital
08/09/22 Piper Sandler
Vivid Seats price target raised to $9 from $8 at Piper Sandler
07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

  • 02
    Jun
  • 08
    Dec
OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

Periodicals
Olaplex looks like a beauty of a bargain, Barron's says » 09:40
10/01/22
10/01
09:40
10/01/22
09:40
OLPX

Olaplex Holdings

$9.55 /

-0.07 (-0.73%)

Olaplex Holdings is an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

09/29/22 Piper Sandler
Olaplex Holdings downgraded to Neutral from Overweight at Piper Sandler
09/07/22 Piper Sandler
Olaplex Holdings price target lowered to $19 from $21 at Piper Sandler
08/10/22 Piper Sandler
Olaplex Holdings price target lowered to $21 from $24 at Piper Sandler
08/03/22 Barclays
Olaplex downgraded to Equal Weight from Overweight at Barclays
OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

Downgrade
BTRS Holdings downgraded to Neutral from Buy at Citi » 09:08
10/01/22
10/01
09:08
10/01/22
09:08
BTRS

BTRS Holdings

$9.26 /

-0.02 (-0.22%)

Citi analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTRS BTRS Holdings
$9.26 /

-0.02 (-0.22%)

BTRS BTRS Holdings
$9.26 /

-0.02 (-0.22%)

09/29/22 Canaccord
BTRS Holdings rating maintained despite takeout bid, says Canaccord
09/28/22 Needham
BTRS Holdings downgraded to Hold from Buy at Needham
03/18/22 Citi
BTRS Holdings price target raised to $13 from $12 at Citi
03/02/22 Canaccord
BTRS Holdings price target lowered to $13 from $17 at Canaccord
BTRS BTRS Holdings
$9.26 /

-0.02 (-0.22%)

BTRS BTRS Holdings
$9.26 /

-0.02 (-0.22%)

BTRS BTRS Holdings
$9.26 /

-0.02 (-0.22%)

General news
Market Summary: » 22:45
09/30/22
09/30
22:45
09/30/22
22:45
$ECON

Economic Data

/

+

Market Summary: stocks…

Market Summary: stocks and bonds ended the day, the week, the month, the quarter, and the year-to-date in the red as high inflation and the FOMC's aggressively hawkish stance to combat it continued to weigh heavily. Additionally, conflicts between fiscal and monetary policy in the G3 are leaving investors jittery. After a relatively bullish bounce to open the day Wall Street closed with losses -1.7% on the Dow and -1.5% on the S&P 500 and NASDAQ. The tumble in the S&P 500 saw it close at 3585, below the 3600 level for the first time since late 2020. For the year, the NASDAQ has plunged -32%, with the S&P 500 off -24.8%, and the Dow -21% lower, the worst 9-month performance to start a year since 2002. Despite the risk-off flows and an early month- and quarter-end bid, Treasuries ended in the red. The 2- and 5-year notes were up about 7 bps to 4.278% and 4.09%, with the 10-year about 4 bps cheaper at 3.828%. For the year, the 2-year is over 400 bps cheaper, with the 5-year 275 bps higher, and the 10-year up 220 bps. The dollar has rallied, however, and finished just off 20 year highs at 112.173 after surging to 114.106 this week following the BoE announcement it would buy bonds due to stability risks. That crushed Sterling with plunged to a record intraday nadir of 1.035 to start the week. Today's data on income, consumption, and inflation all added to the likelihood of a 75 bp Fed hike in November. Fedspeak also promised more tightening ahead.

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
Market Summary: » 22:40
09/30/22
09/30
22:40
09/30/22
22:40
$ECON

Economic Data

/

+

Market Summary: stocks…

Market Summary: stocks and bonds ended the day, the week, the month, the quarter, and the year-to-date in the red as high inflation and the FOMC's aggressively hawkish stance to combat it continued to weigh heavily. Additionally, conflicts between fiscal and monetary policy in the G3 are leaving investors jittery. After a relatively bullish bounce to open the day Wall Street closed with losses -1.7% on the Dow and -1.5% on the S&P 500 and NASDAQ. The tumble in the S&P 500 saw it close at 3585, below the 3600 level for the first time since late 2020. For the year, the NASDAQ has plunged -32%, with the S&P 500 off -24.8%, and the Dow -21% lower, the worst 9-month performance to start a year since 2002. Despite the risk-off flows and an early month- and quarter-end bid, Treasuries ended in the red. The 2- and 5-year notes were up about 7 bps to 4.278% and 4.09%, with the 10-year about 4 bps cheaper at 3.828%. For the year, the 2-year is over 400 bps cheaper, with the 5-year 275 bps higher, and the 10-year up 220 bps. The dollar has rallied, however, and finished just off 20 year highs at 112.173 after surging to 114.106 this week following the BoE announcement it would buy bonds due to stability risks. That crushed Sterling with plunged to a record intraday nadir of 1.035 to start the week. Today's data on income, consumption, and inflation all added to the likelihood of a 75 bp Fed hike in November. Fedspeak also promised more tightening ahead.

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
Alnylam to host conference call » 19:25
09/30/22
09/30
19:25
09/30/22
19:25
ALNY

Alnylam

$200.28 /

-9.16 (-4.37%)

Management will discuss…

Management will discuss the APOLLO-B results on a conference call to be held on September 30 at 8 pm. Webcast Link

ShowHide Related Items >><<
ALNY Alnylam
$200.28 /

-9.16 (-4.37%)

ALNY Alnylam
$200.28 /

-9.16 (-4.37%)

09/20/22 RBC Capital
Alnylam price target raised to $250 from $225 at RBC Capital
09/20/22 Citi
Citi opens 'upside catalyst watch' on Alnylam Pharmaceuticals
09/16/22 Canaccord
Regeneron price target raised to $750 from $700 at Canaccord
09/09/22 Oppenheimer
Alnylam price target raised to $256 from $170 at Oppenheimer
ALNY Alnylam
$200.28 /

-9.16 (-4.37%)

ALNY Alnylam
$200.28 /

-9.16 (-4.37%)

Periodicals
Intel's Mobileye Global files for IPO, Bloomberg reports » 18:27
09/30/22
09/30
18:27
09/30/22
18:27
INTC

Intel

$25.78 /

-0.605 (-2.29%)

Intel has filed for an…

Intel has filed for an initial public offering of its self-driving technology business, Mobileye Global, Bloomberg's Michael Hytha and Ian King report. The company did not disclose terms of the planned share sale in its filing with the U.S. SEC. Mobileye will continue to be controlled by Intel after the IPO, according to the filing. Reference Link

ShowHide Related Items >><<
INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

09/23/22 Morgan Stanley
AMD price target lowered to $95 from $102 at Morgan Stanley
09/08/22 Deutsche Bank
Intel price target lowered to $35 from $38 at Deutsche Bank
09/07/22 Stifel
Stifel starts Intel at Hold with turnaround in 'early innings'
09/07/22 Stifel
Stifel starts AMD at Buy with $122 price target
INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

Hot Stocks
Boeing awarded $188.03M Air Force contract modification » 17:45
09/30/22
09/30
17:45
09/30/22
17:45
BA

Boeing

$121.17 /

-4.18 (-3.33%)

Boeing has been awarded…

Boeing has been awarded an undefinitized contract action with a total not-to-exceed value of $188.03M. This contract modification for the F-15 Japan Super Interceptor Program provides for the Foreign Military Sales, or FMS, requirement to add the Weapon System Trainer hardware and non-recurring engineering for the Japan Air Self Defense Force. Work is expected to be completed by December 31, 2028. This contract involves FMS to Japan. This award is the result of a sole source acquisition. FMS funds in the amount of $25.56M are being obligated at time of award. Air Force Life Cycle Management Center is the contracting activity.

ShowHide Related Items >><<
BA Boeing
$121.17 /

-4.18 (-3.33%)

BA Boeing
$121.17 /

-4.18 (-3.33%)

09/27/22 Morgan Stanley
Boeing's China and MAX 10 risks overdone at current levels, says Morgan Stanley
09/23/22 BofA
Losing Xiamen to Airbus another setback for Boeing, says BofA
09/14/22 Jefferies
Woodward downgraded to Hold from Buy at Jefferies
09/08/22 Morgan Stanley
Boeing price target raised to $233 from $215 at Morgan Stanley
BA Boeing
$121.17 /

-4.18 (-3.33%)

BA Boeing
$121.17 /

-4.18 (-3.33%)

BA Boeing
$121.17 /

-4.18 (-3.33%)

BA Boeing
$121.17 /

-4.18 (-3.33%)

Hot Stocks
Raytheon Technologies awarded $225.64M Navy contract » 17:38
09/30/22
09/30
17:38
09/30/22
17:38
RTX

Raytheon Technologies

$81.86 /

-0.48 (-0.58%)

Raytheon was awarded a…

Raytheon was awarded a $225.64M cost-plus-fixed-fee contract for AIM-9X Block II and Block II+ System Improvement Program Increment IV to include hardware and software development to the AIM-9X system as well as test and integration of developed hardware and capabilities. More specifically the hardware development will include updates to the AIM-9X sensor, electronics unit, and guidance unit and the software efforts include the development of the operational flight software versions 10.5 and 11.5 and integrated flight software. Additionally, this contract provides program protection, cyber security, information assurance and training for the AIM-9X system. Work is expected to be completed in September 2027. This contract was not competitively procured pursuant to Defense Federal Acquisition Regulation 6.302-1. The Naval Air Systems Command is the contracting activity.

ShowHide Related Items >><<
RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

07/27/22 Wells Fargo
Raytheon Technologies price target lowered to $98 from $106 at Wells Fargo
07/27/22 RBC Capital
Raytheon Technologies price target lowered to $115 from $125 at RBC Capital
04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

Hot Stocks
Lockheed Martin awarded $228.68M Navy contract modification » 17:34
09/30/22
09/30
17:34
09/30/22
17:34
LMT

Lockheed Martin

$386.99 /

-2.72 (-0.70%)

Lockheed Martin was…

Lockheed Martin was awarded a not-to-exceed $228.68M cost-plus-award-fee and cost-plus-fixed fee undefinitized modification to a previously awarded contract. This modification adds scope for the development of F-35 training systems and simulation block 4 capability development, to include Joint Strike missiles, weapons, integrated fire control, F-35 Lightning Integrated Training Environment, and additional training development required to meet a Lot 17 delivery. Work is expected to be completed in December 2025. FY22 research, development, test and evaluation funds in the amount of $11.11M, FY22 research, development, test and evaluation funds in the amount of $11.11M, and non-U.S. Department of Defense partner funds in the amount of $5.66M will be obligated at the time of award, none of which will expire at the end of the current fiscal year. The Naval Air Systems Command is the contracting activity.

ShowHide Related Items >><<
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

09/28/22 Wells Fargo
Wells Fargo downgrades Lockheed to sell, says will 'under-grow' peers
09/28/22 Wells Fargo
Lockheed Martin downgraded to Underweight from Equal Weight at Wells Fargo
08/29/22 RBC Capital
Lockheed Martin initiated with a Sector Perform at RBC Capital
07/20/22 Wells Fargo
Lockheed Martin price target lowered to $406 from $496 at Wells Fargo
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

Hot Stocks
Flexible Solutions announces termination of merger pact with Lygos » 17:31
09/30/22
09/30
17:31
09/30/22
17:31
FSI

Flexible Solutions

$1.65 /

-0.05 (-2.94%)

Flexible Solutions and…

Flexible Solutions and Lygos have agreed to terminate the Merger Agreement between the parties. FSI and Lygos remain committed to finding routes to sustainable aspartic acid and the myriad sustainable and biodegradable products that can be made from aspartic acid. Neither FSI nor Lygos will let the termination of the merger agreement prevent them from working together in other ways to achieve the goal of sustainable aspartic acid.

ShowHide Related Items >><<
FSI Flexible Solutions
$1.65 /

-0.05 (-2.94%)

FSI Flexible Solutions
$1.65 /

-0.05 (-2.94%)

11/16/21 Greenridge
Flexible Solutions upgraded to Buy from Hold at Greenridge
FSI Flexible Solutions
$1.65 /

-0.05 (-2.94%)

FSI Flexible Solutions
$1.65 /

-0.05 (-2.94%)

Hot Stocks
Raytheon Technologies awarded $232.78M Navy contract » 17:31
09/30/22
09/30
17:31
09/30/22
17:31
RTX

Raytheon Technologies

$81.86 /

-0.48 (-0.58%)

Raytheon Technologies was…

Raytheon Technologies was awarded a $232.78M cost-plus-incentive-fee contract to procure material and support equipment for depot maintenance facilities and unit level support equipment, as well as to provide program administrative support for non-recurring sustainment activities and supplies, services, and planning for depot standup and expansion in support of the for the F-35 Lightning II Program. Work is expected to be completed in September 2025. This contract was not competitively procured pursuant to 10 U.S.C. 2304. The Naval Air Systems Command is the contracting activity.

ShowHide Related Items >><<
RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

07/27/22 Wells Fargo
Raytheon Technologies price target lowered to $98 from $106 at Wells Fargo
07/27/22 RBC Capital
Raytheon Technologies price target lowered to $115 from $125 at RBC Capital
04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

Syndicate
Worksport files $30M mixed securities shelf  17:24
09/30/22
09/30
17:24
09/30/22
17:24
WKSP

Worksport

$1.75 /

+0.06 (+3.55%)

 
ShowHide Related Items >><<
WKSP Worksport
$1.75 /

+0.06 (+3.55%)

WKSP Worksport
$1.75 /

+0.06 (+3.55%)

11/29/21 Maxim
Worksport initiated with a Buy at Maxim
11/29/21 Maxim
Worksport initiated with a Buy at Maxim
Hot Stocks
Lockheed Martin awarded $265.59M Navy contract modification » 17:23
09/30/22
09/30
17:23
09/30/22
17:23
LMT

Lockheed Martin

$386.99 /

-2.72 (-0.70%)

Lockheed Martin was…

Lockheed Martin was awarded a $265.59M modification to a cost-plus-fixed-fee, firm-fixed-price order against a previously issued basic ordering agreement. This modification exercises options and adds scope to increase Block 4 manufacturing capacity and procure material modification kits and special test/tooling equipment that remove life limits, correct deficiencies, and retrofit aircraft with Technical Refresh 3. These retrofit and modification efforts on F-35 aircraft will be across the U.S. Air Force, U.S. Marine Corps, U.S. Navy, non-U.S. Department of Defense participants and Foreign Military Sales customers. Work will be performed in Fort Worth, Texas and is expected to be completed in September 2028. The Naval Air Systems Command is the contracting activity.

ShowHide Related Items >><<
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

09/28/22 Wells Fargo
Wells Fargo downgrades Lockheed to sell, says will 'under-grow' peers
09/28/22 Wells Fargo
Lockheed Martin downgraded to Underweight from Equal Weight at Wells Fargo
08/29/22 RBC Capital
Lockheed Martin initiated with a Sector Perform at RBC Capital
07/20/22 Wells Fargo
Lockheed Martin price target lowered to $406 from $496 at Wells Fargo
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

Hot Stocks
Lockheed Martin awarded $350.4M Navy contract modification » 17:19
09/30/22
09/30
17:19
09/30/22
17:19
LMT

Lockheed Martin

$386.99 /

-2.72 (-0.70%)

Lockheed Martin was…

Lockheed Martin was awarded a $350.4M cost-plus-incentive-fee and cost-plus-fixed-fee un-priced letter contract modification to a previously awarded and announced unpriced letter contract for program management, engineering development, systems integration, long lead material procurement, and special tooling and equipment procurement in support of missile production. This contract award contains option line items. Work is expected to be completed on November 9, 2026 once the contract is definitized. FY21 research, development, test, and evaluation funds in the amount of $2.85M will be obligated on this award and will expire at the end of the current fiscal year. FY22 research, development, test, and evaluation funds in the amount of $24.28M will be obligated on this award and will not expire at the end of the current fiscal year. This contract is being awarded to the contractor on a sole source basis under 10 U.S.C. 2304(c)(1) and was previously synopsized on the System for Award Management online portal. Strategic Systems Programs is the contracting activity.

ShowHide Related Items >><<
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

09/28/22 Wells Fargo
Wells Fargo downgrades Lockheed to sell, says will 'under-grow' peers
09/28/22 Wells Fargo
Lockheed Martin downgraded to Underweight from Equal Weight at Wells Fargo
08/29/22 RBC Capital
Lockheed Martin initiated with a Sector Perform at RBC Capital
07/20/22 Wells Fargo
Lockheed Martin price target lowered to $406 from $496 at Wells Fargo
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

Hot Stocks
Fluor awarded $1.33B Navy contract modification » 17:15
09/30/22
09/30
17:15
09/30/22
17:15
FLR

Fluor

$24.89 /

+0.45 (+1.84%)

Fluor was awarded a…

Fluor was awarded a $1.33B cost-plus-fixed-fee modification to a previously awarded contract to exercise the FY23 option for Naval Nuclear Propulsion work at the Naval Nuclear Laboratory. Funding will be obligated at time of award, of which, $3.55M will expire at the end of the current fiscal year. This contract modification was not competitively procured. The Naval Sea Systems Command is the contracting activity.

ShowHide Related Items >><<
FLR Fluor
$24.89 /

+0.45 (+1.84%)

FLR Fluor
$24.89 /

+0.45 (+1.84%)

08/08/22 Citi
Fluor price target lowered to $26 from $27 at Citi
07/22/22 Citi
Fluor price target lowered to $27 from $31 at Citi
05/09/22 Citi
Fluor price target raised to $31 from $29 at Citi
02/23/22 Baird
Baird upgrades 'inexpensive' Fluor to Outperform
FLR Fluor
$24.89 /

+0.45 (+1.84%)

Syndicate
Amprius Technologies files to sell 16.83M shares of common stock for holders  17:11
09/30/22
09/30
17:11
09/30/22
17:11
AMPX

Ampex Corp

$9.26 /

-0.24 (-2.53%)

 
ShowHide Related Items >><<
AMPX Ampex Corp
$9.26 /

-0.24 (-2.53%)

AMPX Ampex Corp
$9.26 /

-0.24 (-2.53%)

Hot Stocks
Lytus Technologies receives noncompliance notice from Nasdaq » 17:09
09/30/22
09/30
17:09
09/30/22
17:09
LYT

Lytus Technologies

$1.60 /

+0.08 (+5.26%)

Lytus Technologies…

Lytus Technologies announced that it received a written notice from Nasdaq indicating that the company is not in compliance with Nasdaq Listing Rule 5250 for continued listing because the company had not yet filed its Annual Report of Foreign Private Issuer on Form 20-F for the fiscal year ended March 31. The notice provides that the company has until October 24 to submit a plan to regain compliance with Nasdaq's continued listing requirements. On September 28, the company filed the Form 20-F, and on September 29, the company received a second letter from Nasdaq stating that based on the September 28 filing of the company's Form 20-F, Nasdaq has determined that the company complies with the rule. Accordingly, Nasdaq informed the company that it now considers this matter closed.

ShowHide Related Items >><<
LYT Lytus Technologies
$1.60 /

+0.08 (+5.26%)

  • 14
    Apr
Periodicals
Bundesliga reopens investment talks with KKR, Blackstone, others, FT says » 17:08
09/30/22
09/30
17:08
09/30/22
17:08
KKR

KKR

$43.01 /

-0.28 (-0.65%)

, BX

Blackstone

$83.72 /

-0.77 (-0.91%)

Germany's Bundesliga…

Germany's Bundesliga football league has reopened discussions with buyout groups over a multibillion-euro investment, the Financial Times' Josh Noble and Kaye Wiggins reports. In recent weeks, executives from Deutsche Fussball Liga, which runs the Bundesliga, have held early discussions with private equity firms, including Advent, Blackstone (BX), Bridgepoint, CVC, and KKR (KKR), the authors say, citing two people familiar with the matter. One option discussed would be to establish an entity that would control Bundesliga's media and commercial rights, valuing them at as much as EUR18B, and then raise up to EUR4.5B by selling a 25% interest to external investors, the authors note. Reference Link

ShowHide Related Items >><<
KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

KKR KKR
$43.01 /

-0.28 (-0.65%)

08/12/22 Deutsche Bank
KKR price target raised to $68 from $65 at Deutsche Bank
07/13/22 Deutsche Bank
KKR price target lowered to $66 from $79 at Deutsche Bank
07/12/22 JMP Securities
KKR price target lowered to $80 from $85 at JMP Securities
07/11/22 Piper Sandler
KKR price target lowered to $80 from $86 at Piper Sandler
BX Blackstone
$83.72 /

-0.77 (-0.91%)

08/31/22 Barclays
Blackstone initiated with an Overweight at Barclays
08/12/22 Deutsche Bank
Blackstone price target raised to $153 from $147 at Deutsche Bank
07/25/22 Piper Sandler
Blackstone price target lowered to $120 from $154 at Piper Sandler
07/24/22 Keefe Bruyette
Blackstone downgraded to Market Perform from Outperform at Keefe Bruyette
KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

  • 08
    Dec
KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

Syndicate
Xos files to sel 11.57M shares of common stock for holders  17:08
09/30/22
09/30
17:08
09/30/22
17:08
XOS

Xos

$1.23 /

-0.04 (-3.15%)

 
ShowHide Related Items >><<
XOS Xos
$1.23 /

-0.04 (-3.15%)

XOS Xos
$1.23 /

-0.04 (-3.15%)

08/12/22 DA Davidson
Xos price target lowered to $5 from $11 at DA Davidson
07/15/22 Northland
Sunworks and Sunnova could trade down on Manchin news, says Northland
06/03/22 Northland
Xos initiated with an Outperform at Northland
12/08/21 BofA
Xos initiated with an Underperform at BofA
XOS Xos
$1.23 /

-0.04 (-3.15%)

XOS Xos
$1.23 /

-0.04 (-3.15%)

Syndicate
Predictive Oncology files to sell 4.74M shares of common stock for holders  17:08
09/30/22
09/30
17:08
09/30/22
17:08
POAI

Predictive Oncology

/

+

 
ShowHide Related Items >><<
POAI Predictive Oncology
/

+

Syndicate
Warrior Met Coal files automatic mixed securities shelf  17:07
09/30/22
09/30
17:07
09/30/22
17:07
HCC

Warrior Met Coal

$28.44 /

-0.59 (-2.03%)

 
ShowHide Related Items >><<
HCC Warrior Met Coal
$28.44 /

-0.59 (-2.03%)

HCC Warrior Met Coal
$28.44 /

-0.59 (-2.03%)

09/23/22 B. Riley
Warrior Met Coal upgraded to Buy from Neutral at B. Riley
08/03/22 BMO Capital
Warrior Met Coal downgraded to Market Perform from Outperform at BMO Capital
07/07/22 B. Riley
Warrior Met Coal price target raised to $48 from $45 at B. Riley
06/07/22 Jefferies
Warrior Met Coal upgraded to Buy from Hold at Jefferies
HCC Warrior Met Coal
$28.44 /

-0.59 (-2.03%)

Hot Stocks
Regeneron reports 'positive' results from trials of novel aflibercept 8mg » 17:06
09/30/22
09/30
17:06
09/30/22
17:06
REGN

Regeneron

$689.40 /

-2.865 (-0.41%)

Regeneron announced the…

Regeneron announced the first presentations of positive detailed results from two pivotal trials investigating novel aflibercept 8 mg with 12- and 16-week dosing regimens, compared to EYLEA Injection, in patients with diabetic macular edema and wet age-related macular degeneration. The data were presented in a late-breaking session at the American Academy of Ophthalmology annual meeting in Chicago and will support the submission of a new Biologics License Application to the U.S. FDA by early 2023. "Our presentations at AAO demonstrate that aflibercept 8 mg 12- and 16-week dosing regimens have achieved a high bar, sustaining improvements in visual acuity and anatomic measures of retinal fluid across 48 weeks in patients with diabetic macular edema and wet age-related macular degeneration," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer at Regeneron, and a principal inventor of aflibercept. "These results were all achieved in patients who were rapidly initiated on extended dosing intervals with the vast majority not requiring regimen modification. Altogether, the pivotal data support aflibercept 8 mg as providing a longer duration of action while maintaining a safety profile similar to EYLEA." As presented at AAO, the PHOTON trial in DME and the PULSAR trial in wAMD both met the same primary endpoint. Aflibercept 8 mg demonstrated non-inferiority in vision gains in both the 12- and 16-week dosing regimens after initial monthly doses at 48 weeks compared to an EYLEA 8-week dosing regimen. Furthermore, 91% and 89% of DME patients and 79% and 77% of wAMD patients respectively randomized to 12- and 16-week dosing maintained those intervals through 48 weeks. The safety of aflibercept 8 mg was similar to EYLEA in both trials, and consistent with the known safety profile of EYLEA from previous clinical trials. Comparing aflibercept 8 mg to EYLEA, ocular adverse events occurred in 31% versus 28% in PHOTON and 38% versus 39% in PULSAR, and there were no cases of retinal vasculitis, occlusive retinitis or endophthalmitis in either trial.

ShowHide Related Items >><<
REGN Regeneron
$689.40 /

-2.865 (-0.41%)

REGN Regeneron
$689.40 /

-2.865 (-0.41%)

09/16/22 Canaccord
Regeneron price target raised to $750 from $700 at Canaccord
09/13/22 Piper Sandler
Regeneron price target raised to $775 from $692 at Piper Sandler
09/12/22 Piper Sandler
Regeneron data at ESMO showcases 'power' of oncology pipeline, says Piper
09/12/22 Guggenheim
Regeneron price target raised to $925 from $740 at Guggenheim
REGN Regeneron
$689.40 /

-2.865 (-0.41%)

REGN Regeneron
$689.40 /

-2.865 (-0.41%)

REGN Regeneron
$689.40 /

-2.865 (-0.41%)

REGN Regeneron
$689.40 /

-2.865 (-0.41%)

Hot Stocks
Stealth Biotherapeutics announces resignation of CFO Robert Weiskopf » 17:01
09/30/22
09/30
17:01
09/30/22
17:01
MITO

Stealth Biotherapeutics

/

+

Stealth BioTherapeutics…

Stealth BioTherapeutics announced that Robert Weiskopf, Stealth's CFO, is leaving the company effective September 30. Weiskopf joined Stealth in 2019 following the company's initial public offering to spearhead its public financial reporting activities and grow the company's financial team.

ShowHide Related Items >><<
MITO Stealth Biotherapeutics
/

+

MITO Stealth Biotherapeutics
/

+

05/23/22 H.C. Wainwright
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright
MITO Stealth Biotherapeutics
/

+

Periodicals
Intel's Mobileye Global files for IPO, Bloomberg reports » 16:59
09/30/22
09/30
16:59
09/30/22
16:59
INTC

Intel

$25.78 /

-0.605 (-2.29%)

Mobileye Global will seek…

Mobileye Global will seek listing on Nasdaq under ticker symbol "MBLY."

ShowHide Related Items >><<
INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

09/23/22 Morgan Stanley
AMD price target lowered to $95 from $102 at Morgan Stanley
09/08/22 Deutsche Bank
Intel price target lowered to $35 from $38 at Deutsche Bank
09/07/22 Stifel
Stifel starts Intel at Hold with turnaround in 'early innings'
09/07/22 Stifel
Stifel starts AMD at Buy with $122 price target
INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.